Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 6
2010 3
2011 2
2012 1
2013 4
2014 6
2015 7
2016 7
2017 9
2018 11
2019 12
2020 22
2021 14
2022 29
2023 25
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Boosting healthier choices.
Rouyard T, Engelen B, Papanikitas A, Nakamura R. Rouyard T, et al. Among authors: nakamura r. BMJ. 2022 Jan 4;376:e064225. doi: 10.1136/bmj-2021-064225. BMJ. 2022. PMID: 34983778 Free PMC article.
Surgical treatment of pulmonary bullous diseases.
Satoh H, Iguchi K, Nakamura R. Satoh H, et al. Among authors: nakamura r. Lung India. 2023 Jan-Feb;40(1):95-96. doi: 10.4103/lungindia.lungindia_444_22. Lung India. 2023. PMID: 36695271 Free PMC article. No abstract available.
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.
Katayama Y, Yamada T, Tanimura K, Tokuda S, Morimoto K, Hirai S, Matsui Y, Nakamura R, Ishida M, Kawachi H, Yoneda K, Hosoya K, Tsuji T, Ozasa H, Yoshimura A, Iwasaku M, Kim YH, Horinaka M, Sakai T, Utsumi T, Shiotsu S, Takeda T, Katayama R, Takayama K. Katayama Y, et al. Among authors: nakamura r. NPJ Precis Oncol. 2023 Jan 26;7(1):12. doi: 10.1038/s41698-023-00350-7. NPJ Precis Oncol. 2023. PMID: 36702855 Free PMC article.
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells.
Hirai S, Yamada T, Katayama Y, Ishida M, Kawachi H, Matsui Y, Nakamura R, Morimoto K, Horinaka M, Sakai T, Sekido Y, Tokuda S, Takayama K. Hirai S, et al. Among authors: nakamura r. Mol Cancer Ther. 2024 Feb 1;23(2):212-222. doi: 10.1158/1535-7163.MCT-23-0138. Mol Cancer Ther. 2024. PMID: 37802502 Free PMC article.
Analysis of Tumor Heterogeneity Through AXL Activation in Primary Resistance to EGFR Tyrosine Kinase Inhibitors.
Nakamura R, Fujii H, Yamada T, Matsui Y, Yaoi T, Honda M, Tanaka N, Miyagawa-Hayashino A, Yoshimura A, Morimoto K, Iwasaku M, Tokuda S, Kim YH, Konishi E, Itoh K, Takayama K. Nakamura R, et al. JTO Clin Res Rep. 2023 May 12;4(6):100525. doi: 10.1016/j.jtocrr.2023.100525. eCollection 2023 Jun. JTO Clin Res Rep. 2023. PMID: 37426308 Free PMC article.
Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson's disease in Japan.
Oyama G, Burq M, Hatano T, Marks WJ Jr, Kapur R, Fernandez J, Fujikawa K, Furusawa Y, Nakatome K, Rainaldi E, Chen C, Ho KC, Ogawa T, Kamo H, Oji Y, Takeshige-Amano H, Taniguchi D, Nakamura R, Sasaki F, Ueno S, Shiina K, Hattori A, Nishikawa N, Ishiguro M, Saiki S, Hayashi A, Motohashi M, Hattori N. Oyama G, et al. Among authors: nakamura r. Sci Rep. 2023 Mar 14;13(1):3600. doi: 10.1038/s41598-023-29382-6. Sci Rep. 2023. PMID: 36918552 Free PMC article.
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.
Morimoto K, Yamada T, Hirai S, Katayama Y, Fukui S, Sawada R, Tachibana Y, Matsui Y, Nakamura R, Ishida M, Kawachi H, Kunimasa K, Sasaki T, Nishida M, Furuya N, Watanabe S, Shiotsu S, Nishioka N, Horinaka M, Sakai T, Uehara H, Yano S, Son BK, Tokuda S, Takayama K. Morimoto K, et al. Among authors: nakamura r. Cancer Lett. 2024 Apr 10;587:216692. doi: 10.1016/j.canlet.2024.216692. Epub 2024 Feb 9. Cancer Lett. 2024. PMID: 38342232 Free article.
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study.
Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Nakamura R, Tsunemi T, Ogawa T, Eguchi H, Daida K, Kurita N, Ueno SI, Fukae J, Sako W, Shiina K, Nakajima S, Oji Y, Wakamori R, Saiki S, Nishioka K, Okuzumi A, Taniguchi D, Takeshige-Amano H, Fuse A, Nakajima A, Kano M, Kamo H, Yamashita Y, Shindo A, Yanagisawa N, Hattori N. Hatano T, et al. Among authors: nakamura r. Mov Disord Clin Pract. 2024 Apr;11(4):352-362. doi: 10.1002/mdc3.13972. Epub 2024 Jan 24. Mov Disord Clin Pract. 2024. PMID: 38264844 Free PMC article. Clinical Trial.
150 results